ReviewFrontiers in immunology2026
Vitamin D as a central modulator of thyroid diseases: mechanisms and clinical implications.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Vitamin D and gut microbiota in thyroid diseases: mechanisms and therapeutic potential.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid diseases are common endocrine disorders, with the incidence of thyroid cancer and autoimmune thyroid diseases rising worldwide. Vitamin D, a multifunctional steroid hormone, primarily regulates bone metabolism and calcium-phosphorus homeostasis. However, recent evidence increasingly supports the hypothesis that vitamin D plays a central role in the onset and progression of thyroid disorders, including both autoimmune and non-autoimmune conditions. In the present review, we summarize the correlation between vitamin D and thyroid disorders, elucidate the anticancer and immunoregulatory mechanisms of vitamin D in thyroid diseases, and explore its role in modulating gut microbiota. Additionally, we examine the applications in clinical settings of the use of vitamin D supplements in thyroid disorders, such as a preventive measure against cancer development and progression. Clarifying the mechanisms of vitamin D action in the development and progression of thyroid disease will support the design of interventional and early therapeutic strategies that not only prevent disease onset but also serve as a secondary chemopreventive approach to halt progression and enhance thyroid function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.